Advertisement
Screener

CeriBell, Inc. (CBLL) EBITDA

CeriBell, Inc. (CBLL) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$19.74M*; Operating income -$19.98M; Depreciation and amortization $245.00K*.
  • 2026-03-31: Basis Reported; EBITDA -$20.51M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$14.31M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$14.26M*; Operating income -$14.65M; Depreciation and amortization $391.00K*.

Complete source-backed ebitda history.

Available history
2023-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$19.74M*-$19.98M$245.00K*$28.10M-70.24%*$17.00K*-$12.86M*(m)$6.75M(m)$0.00
2026-03-31Reported-$20.51M(m)(m)(m)-77.40%$125.00K-$19.30M(m)$6.16M(m)(m)
2025-12-31Reported-$14.31M(m)(m)(m)-57.72%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$14.26M*-$14.65M$391.00K*$22.59M-63.11%*$369.00K*-$11.10M*(m)$4.98M(m)(m)
2025-06-30Reported-$14.63M*-$14.95M$324.00K*$21.20M-69.00%*$71.00K*-$7.53M*(m)$4.85M(m)$0.00
2025-03-31Reported-$13.87M(m)(m)(m)-67.70%$148.00K-$11.40M(m)$4.25M(m)(m)
2024-12-31Reported-$12.52M(m)(m)(m)-67.55%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$9.69M*-$9.94M$243.00K*$17.20M-56.38%*$567.00K*-$8.54M*(m)$3.40M(m)(m)
2024-06-30Reported-$8.16M*-$8.44M$277.00K*$15.31M-53.27%*$321.00K*-$6.98M*(m)$3.27M(m)(m)
2024-03-31Reported-$8.2M(m)(m)(m)-56.92%$95.00K-$9.55M(m)$2.98M(m)(m)
2023-12-31Reported-$8.15M(m)(m)(m)-62.05%(m)(m)(m)(m)(m)(m)
2023-09-30Reported(m)-$7.16M(m)$11.61M(m)(m)(m)(m)$2.31M(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$57.06M(m)(m)(m)-64.07%$767.00K-$40.81M(m)$19.14M(m)$0.00
2024-12-31Reported-$38.57M(m)(m)(m)-58.93%$1.34M-$35.04M(m)$13.56M(m)$0.00
2023-12-31Reported-$29.19M(m)(m)(m)-64.55%$983.00K-$29.16M(m)$8.99M(m)$11.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
CONMED Corp (CNMD)United States$1.353B26.72
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Streamex Corp. (STEX)United States$0.089B-0.19